1. | | Recruiting | Avastin/Placebo + Tarceva or Taxotere for Second-line Advanced Non-small Cell Lung Cancer Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Adenocarcinoma; Carcinoma, Large Cell |
2. | | Recruiting | Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer Condition: Non-Small-Cell Lung Cancer |
3. | | Recruiting | Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Conditions: Carcinoma, Non-Small-Cell Lung; Lung Cancer |
4. | | Recruiting | Study to Evaluate AMG 706 with or without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC) Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
5. | | Recruiting | Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
6. | | Recruiting | CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
7. | | Recruiting | Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
8. | | Recruiting | Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ... |
9. | | Recruiting | ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
10. | | Recruiting | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer with Simultaneous Radiotherapy Conditions: Carcinoma, Non-Small Cell Lung; Lung Cancer |
11. | | Recruiting | Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
12. | | Recruiting | Vaccine Therapy and Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
13. | | Not yet recruiting | Pulmonary Rehabilitation Education With or Without Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemotherapy and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer Conditions: Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; ... |
14. | | Recruiting | A Cancer Vaccine (CG8123) Given with and without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
15. | | Recruiting | Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer Condition: stage I non-small cell lung cancer |
16. | | Not yet recruiting | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
17. | | Recruiting | Celecoxib and Gefitinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
18. | | Recruiting | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer Conditions: Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer |
19. | | Recruiting | EPO906 in Patients with Late Stage Non-Small-Cell Lung Cancer (NSCLC) Conditions: Non-small cell lung cancer; NSCLC |
20. | | Recruiting | STA-4783 in Combination with Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients with Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
21. | | Recruiting | Alimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Condition: Pleural Neoplasms |
22. | | Not yet recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ... |
23. | | Recruiting | Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
24. | | Not yet recruiting | Erlotinib in Treating Patients With Early-Stage Non-Small Cell Lung Cancer Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
25. | | Recruiting | Advanced Or Metastatic Non-Small Cell Lung Cancer Study In Patients Who Have Received One Platinum-based Chemotherapy Condition: Non-small cell lung cancer |
26. | | Recruiting | Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
27. | | Not yet recruiting | Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
28. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
29. | | Recruiting | FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
30. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
31. | | Recruiting | Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease Conditions: Non-small cell lung cancer; Small Cell Lung Cancer |
32. | | Recruiting | Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
33. | | Not yet recruiting | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
34. | | Recruiting | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain Conditions: Breast Cancer; Lung Cancer; metastatic cancer; Pain; Prostate Cancer |
35. | | Recruiting | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC) Condition: NSCLC |
36. | | Recruiting | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients with Unresectable Non-Small Cell Lung Cancer Conditions: Esophagitis; Pneumonitis; Non-small cell lung cancer |
37. | | Recruiting | Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ... |
38. | | Recruiting | Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
39. | | Not yet recruiting | Temozolomide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Conditions: brain metastases; Non-small cell lung cancer |
40. | | Recruiting | ABT-751 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That is Refractory to Taxane Therapy Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
41. | | Recruiting | Effectiveness of KOS-862 in the Treatment of Lung Cancer Condition: Lung Cancer |
42. | | Recruiting | Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer Condition: Lung Cancer |
43. | | Recruiting | Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors Conditions: Breast Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Lung Neoplasms |
44. | | Recruiting | Motexafin Gadolinium with Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Conditions: Head and Neck Cancer; Oropharynx Cancer; Larynx Cancer; Hypopharynx Cancer |
45. | | Not yet recruiting | Iscar for Supplemental Care in Stage IV Lung Cancer Condition: Lung Cancer |
46. | | Recruiting | Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer Conditions: Adenocarcinoma of the Lung; large cell lung cancer; recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; ... |
47. | | Recruiting | Monoclonal Antibody ABX-EGF as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
48. | | Recruiting | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer |
49. | | Recruiting | Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer Conditions: Non Small Cell Lung Cancer; Lung Cancer; Stage IIIA non small cell lung cancer; Stage IIIB non small cell lung cancer |
50. | | Recruiting | TLK286 (Telcyta) in Combination with Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Condition: Non-small cell lung cancer |